• The target trendline in the graph above represents an accepted national benchmark percentile for Medicaid programs across the country. The value graphed historically was the national 50^th percentile for comparison purposes. In 2020 (for measurement year 2019) we modified the value shown to demonstrate a target based on our actual performance.  For this measure, the target is the 90^th national percentile.
• The annual reported rate captures activity during the previous calendar year. 
• This is a Healthcare Effectiveness & Data Information Set (HEDIS) administrative measure.
• DVHA’s rates only include Medicaid Primary beneficiaries in HEDIS administrative measures.

This measure assesses the percentage of members with schizophrenia who were 19-64 years of age during the measurement year and were dispensed and remained on antipsychotic medication for at least 80% of the treatment period.

For people with schizophrenia, nonadherence to treatment with antipsychotics is common, and medication nonadherence is a significant cause of relapse.  Measuring antipsychotic medication adherence may lead to less relapse and fewer hospitalizations.  Additionally, there is potential to lead to interventions to improve adherence and help close the gap in care between people with schizophrenia and the general population.

Last updated:  August 2021